Human IL12A & IL27B Heterodimer Protein
CLMF,IL-12A,NFSK,NKSF1,P35
- 100ug (NPP1744) Please inquiry
Catalog Number | PCT040-H0323H |
---|---|
Organism Species | Human |
Host | Human Cells |
Synonyms | CLMF,IL-12A,NFSK,NKSF1,P35 |
Molecular Weight | The recombinant human IL12A&IL27B comprises 905 (447+458) amino acids and has a calculated molecular mass of 102 (50.7+ 51.3) KDa. The apparent molecular mass of the recombinant human IL12A&IL27B is approximately 60 & 63 KDa respectively in SDS-PAGE under reducing conditions. |
predicted N | Arg 23 & Arg 21 |
SDS-PAGE | |
Purity | (59.8+33.3) % as determined by SDS-PAGE |
Protein Construction | A DNA sequence encoding the p35 subunit of human IL12, termed as IL12A (NP_000873.2) (Met1-Ser219) was fused with the C-terminal His-tagged Fc region of human IgG1 at the C-terminus, constructed the plasmid 1; A DNA sequence encoding the human IL27B, (NP_005746.2) (Met1-Lys229) was fused with the C-terminal flag-tagged Fc region of human IgG1 at the C-terminus, constructed the plasmid 2. The two plasmids were co-expressed and the heterodimer was purified. |
Bio-activity | |
Research Area | Cancer |Cancer immunology |Cytokine & Receptor |Interleukin & Receptor |IL-12 family & Receptor |IL-12 family ligand | |
Formulation | Lyophilized from sterile PBS, pH 7.4. 1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA. |
Background | IL12A is a subunit of a cytokine that acts on T and natural killer cells, and has a broad array of biological activities. IL12A, together with IL27B, form a disulfide-linked heterodimer: IL12A&IL27B. IL12A&IL27B is required for the T-cell-independent induction of IFN-gamma, and is important for the differentiation of both Th1 and Th2 cells. The responses of lymphocytes to this cytokine are mediated by the activator of transcription protein STAT4. Nitric oxide synthase 2A (NOS2A/NOS2) is found to be required for the signaling process of IL12A&IL27B in innate immunity. |
Reference |